Profile
Full Name
Forte Biosciences, Inc.Ticker Symbol
FBRXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
April 13, 2017Indexes
Not includedWebsite
http://www.fortebiorx.comEmployees
14Key Details
Price
$7.34(+1.10%)
Market cap
$48.31M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$12.17(+51.16% YoY)
PE ratio
-
Next earnings date
May 13, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Forte Biosciences doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 1, 25 Chardan Capital
BuyJan 21, 25 TD Cowen
BuyDec 4, 24 Chardan Capital
BuyNov 15, 24 Chardan Capital
BuyAug 19, 24 Chardan Capital
BuyMay 30, 24 Brookline Capital
BuyApr 8, 24 Ladenburg Thalmann
BuySep 20, 21 Chardan Capital
NeutralSep 3, 21 Truist Securities
HoldSep 3, 21 Ladenburg Thalmann
NeutralInstitutional Ownership
- What is the ticker symbol for Forte Biosciences?
- Does Forte Biosciences pay dividends?
- What sector is Forte Biosciences in?
- What industry is Forte Biosciences in?
- What country is Forte Biosciences based in?
- When did Forte Biosciences go public?
- Is Forte Biosciences in the S&P 500?
- Is Forte Biosciences in the NASDAQ 100?
- Is Forte Biosciences in the Dow Jones?
- When was Forte Biosciences's last earnings report?
- When does Forte Biosciences report earnings?
- Should I buy Forte Biosciences stock now?
What is the ticker symbol for Forte Biosciences?
The ticker symbol for Forte Biosciences is NASDAQ:FBRX
Does Forte Biosciences pay dividends?
No, Forte Biosciences does not pay dividends
What sector is Forte Biosciences in?
Forte Biosciences is in the Healthcare sector
What industry is Forte Biosciences in?
Forte Biosciences is in the Biotechnology industry
What country is Forte Biosciences based in?
Forte Biosciences is headquartered in United States
When did Forte Biosciences go public?
Forte Biosciences's initial public offering (IPO) was on April 13, 2017
Is Forte Biosciences in the S&P 500?
No, Forte Biosciences is not included in the S&P 500 index
Is Forte Biosciences in the NASDAQ 100?
No, Forte Biosciences is not included in the NASDAQ 100 index
Is Forte Biosciences in the Dow Jones?
No, Forte Biosciences is not included in the Dow Jones index
When was Forte Biosciences's last earnings report?
Forte Biosciences's most recent earnings report was on Mar 31, 2025
When does Forte Biosciences report earnings?
The next expected earnings date for Forte Biosciences is May 13, 2025
Should I buy Forte Biosciences stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions